Showing posts with label tumors. Show all posts
Showing posts with label tumors. Show all posts

Wednesday, April 8, 2009

Sarcomatoid Mesothelioma: A Deadly Curse Of Asbestos


Sarcomatoid Mesotheliom is a rather rare kind of cancer caused because of the asbestos exposure. While it is difficult to determine Sarcomatoid Mesotheliom it hardly reacts in any kind therapy. This is all diseases standing asbestos in connection the most serious. The possibility of finding this kind of cancer is on the lips and the larynx. However in certain cases it can affect the oral cavity in addition. Like all further forms of Mesotheliomkrebsen, this cancer is reacted hardly a deadly illness and on each possible working method. Although radiotherapy for the treatment of these cancer-like tumors is recommended, but, some of them be not radiation-sensitive and can radiation for treatment can provoke.

Diagnosis of the Sarcomatoid Mesothelioms:

The distinction sarcomatoid of the Mesothelioms of other cell tumors by light microscopy is rather difficult. The role of immunohistochemistry is not well defined also in its diagnosis. Since sarcomatoid Mesotheliom is not always cytokeratin negative, the distinction between it and Sarkom is not always possible. In this connection the doctors took up themselves a study, in order to investigate the utility program of Diagnoseimmunohistochemistry for differentiating sarcomatoid the Mesothelioms of its histological imitators, of high-quality Sarkom and of sarcomatoid cancer of the lungs ulcer.

For his study the researchers stained the Mesotheliome with sarcomatoid components. They determined the intensity and the distribution of staining assistance of a half quantitative scale. Only tumors with unmistakable staining were considered as positive for scheduling. Then they compared the immune OF of profiles of these tumors with 24 high-quality Sarkomen. Sarcomatoid the cancer ulcers were stained also for thyroid transmission factor-1 (TTF-1).

The study showed the fact that Cytokeratin 5/6 stained most epithelioids was stained rarely but sarcomatoids. On the one hand Calretinin stained and thrombomodulin each 70% of sarcomatoid. All 10 sarcomatoids was negative for TTF-1. This led to the summary that broad immune OF exists a covering under different sarcomatoids. Cytokeratin and calretinin have most value, if they differentiate between different sarcomatoids. Clinical-pathological data, particularly information over the rough appearance of the tumor are rather important for sarcomatoid tumors. So it should be noticed with the microscopic and immunohistochemical discoveries and referred carefully one on the other.


sarcomatoid, mesothelioma, tumors, stained, sarcomatoids, study, cytokeratin, treatment, quite, cancer, diagnostic immunohistochemistry, asbestos related diseases, cancerous tumors, light microscopy, cell tumors, asbestos exposure, oral cavity, calretinin, sarcomatoid carcinoma, uncommon type, type of cancer, transcription factor, radiation therapy, carcinomas, larynx, mesothelioma, ttf, carcinoma, tabulation, differentiation

Saturday, January 17, 2009

Breast Cancer

Breast cancer occurs when cells in the breast begin to grow out of control that allow them to invade nearby tissues or spread throughout the body. Collections of these out of control are called tumors tissues. However, not all breast tumors are considered cancer and some types of large cells can not be spread or threaten a person's life and this kind of tumor is called benign tumor. Moreover, tumors that can spread throughout the body or invade nearby tissues are considered cancer cells and are malignant. Cancer cells usually comes from the glands or ducts, either in the breast is why it can take months or even years for a tumor that was announced in the chest. Breast tumors are selected with the use of mammograms that are fairly accurate in screening for cancer or tumor cells.
Women are much more likely to develop breast cancer than men. Only 1% to 2% of men are known to have cases of breast cancer. The early onset of menstruation in women of age 12 years increases the risk of breast cancer in the other party a period of early menopause may reduce the risk of breast cancer. The risk that women have breast cancer increases with age, in fact, a study shows that women over 50 years are more likely to develop breast cancer. However, the incidence of breast cancer among young women is also increasing at an alarming is the reason that more women aged 20 to 30 years have undergone a diagnosis.
Breast cancer is not only acquired, but can be inherited. For women who have BRCA1 or BRCA2 gene mutation have a 80% risk of developing breast cancer. Women who have been diagnosed with first-degree breast cancer also increase the risk of breast cancer. Moreover, women with first-degree relative who are diagnosed with breast cancer before menopause increase the risk for them in the purchase of breast cancer.
Some factors that contribute to the onset of breast cancer and these are: the snuff, alcohol and exposure to radiation. Women who smoke increase their chances of getting breast cancer. Besides, a high intake of alcohol has been proved to be a source of breast cancer. Exposure to radiation is another factor that contributes to breast cancer. Studies have shown that women and children who have undergone high-dose radiation therapy have a much greater chance of having breast cancer.